Financials in USD. Standardized financial statements.
A compact view of how Global Cord Blood Corporation turns revenue into operating income and net income.
| Metric | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $1.24B | $1.16B | $1.22B | $986.75M | $936.77M | $759.98M | $663.00M | $635.12M | $572.86M | $526.12M |
| Revenue Growth? | +7.2% | -5.1% | +23.8% | +5.3% | +23.3% | +14.6% | +4.4% | +10.9% | +8.9% | 0.0% |
| Cost of Revenue? | $183.31M | $178.95M | $189.13M | $186.03M | $181.48M | $142.64M | $144.60M | $130.61M | $106.22M | $106.62M |
| Gross Profit? | $1.06B | $980.69M | $1.03B | $800.73M | $755.28M | $617.34M | $518.40M | $504.51M | $466.63M | $419.50M |
| Gross Margin? | +85.3% | +84.6% | +84.5% | +81.1% | +80.6% | +81.2% | +78.2% | +79.4% | +81.5% | +79.7% |
| Operating Expenses? | $451.08M | $435.82M | $473.30M | $419.07M | $475.42M | $352.47M | $327.07M | $269.51M | $234.71M | $210.19M |
| Operating Income? | $608.87M | $544.87M | $559.03M | $381.66M | $279.86M | $264.87M | $191.33M | $235.00M | $231.93M | $209.31M |
| EBITDA? | $656.79M | $593.96M | $608.48M | $434.02M | $353.60M | $333.71M | $299.10M | $306.33M | $297.44M | $264.16M |
| Income Before Tax | $627.84M | $610.75M | $578.81M | $356.46M | $303.54M | $166.31M | $141.33M | $155.12M | $190.92M | $158.19M |
| Income Tax Expense | $118.35M | $94.55M | $101.08M | $61.26M | $62.66M | $37.62M | $50.00M | $47.33M | $58.40M | $38.54M |
| Net Income? | $501.06M | $508.25M | $470.72M | $291.12M | $237.10M | $126.19M | $90.97M | $107.29M | $131.90M | $112.45M |
| EPS? | $4.12 | $4.18 | $3.87 | $2.40 | $1.99 | $1.59 | $1.25 | $1.36 | $1.60 | $1.49 |
| Diluted EPS? | $4.12 | $4.18 | $3.87 | $2.40 | $1.99 | $1.59 | $1.25 | $1.36 | $1.60 | $1.49 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality